Safe Care CommitmentGet the latest news on COVID-19, the vaccine and care at Mass General.Learn more
Dr. Sarita Patil earned a BA in Human Biology with Honors from Stanford University and an MD from Duke University, which included a Howard Hughes Medical Research Fellowship. She completed her clinical training with an Internal Medicine residency at the University of Pennsylvania followed by her Allergy and Immunology fellowship at Massachusetts General Hospital (MGH).
Since then, she has continued to serve on the faculty at MGH and is currently an Assistant Professor in the Division of Rheumatology, Allergy, and Immunology in the Department of Medicine and in the Division of Allergy and Immunology in the Department of Pediatrics.
She is a physician-scientist who specializes in the treatment of patients with food allergy and is a member of the MGH Food Allergy Center. She is also the allergist for the adult Eosinophilic Gastrointestinal Diseases Clinic, which specializes in the care of patients affected by Eosinophilic Esophagitis (EoE) and Eosinophilic Gastrointestinal Disease (EGID).
Her laboratory, in the Center for Immunology and Inflammatory Diseases, focuses on understanding antibody and B cell responses in both the initiation and treatment of allergic diseases, with a particular focus on food allergies.
Clinical Interests:
Treats:
Languages:
Allergy Associates
55 Fruit Street
Boston, MA 02114-2696
Phone: 617-726-3850
Fax: 627-724-0239
Medical Education
American Board Certifications
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Antibodies play a central role in allergic diseases. The Patil Laboratory at Massachusetts General Hospital is focused on the study of allergen-specific antibodies in allergic diseases. We are focused on understanding and harnessing protective antibodies induced by immunotherapy for food allergies. In the course of our investigation, we have developed new techniques to study antigen-specific B cells, including the use of fluorescent multimers. Combined with single-cell B cell receptor sequencing and deep sequencing of the antibody repertoire, we have been able to better understand the development of clinical tolerance in immunotherapy.
We believe that by understanding the development and functionality of antigen-specific B cells, the B cell repertoire and protective antibodies, we will be able to contribute to the next generation of therapies.
